Clinical Trial Update: Functional Precision Oncology for Metastatic Breast Cancer [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study on functional precision oncology for metastatic breast cancer in HER2-negative disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Utah | Conditions: HER2-negative Breast Cancer | NA | Status: COMPLETED